Rasagiline Tablets   4

Background
The solicitation SPE2D2-25-R-0020 is issued by the Defense Logistics Agency (DLA) for the procurement of Rasagiline Tablets. The DLA's mission is to provide logistics support to the military and other government agencies, ensuring that they have the necessary supplies and equipment. The goal of this contract is to supply Rasagiline Tablets, which are used in the treatment of Parkinson's disease, thereby supporting public health initiatives.

Work Details
The contract entails the delivery of Rasagiline Tablets in two dosages: 0.5 MG and 1 MG, each packaged in bottles of 30 count. The estimated quantities for each item are as follows:

- Item No. 0001: Rasagiline 0.5 MG Tablet – 30 Count
- Base Year: 5,828 Bottles
- Option Year 1: 5,828 Bottles
- Option Year 2: 5,828 Bottles
- Option Year 3: 5,828 Bottles
- Option Year 4: 5,828 Bottles

- Item No. 0002: Rasagiline 1 MG Tablet – 30 Count
- Base Year: 35,099 Bottles
- Option Year 1: 35,099 Bottles
- Option Year 2: 35,099 Bottles
- Option Year 3: 35,099 Bottles
- Option Year 4: 35,099 Bottles

*Note that package sizes are subject to the Statement of Work requirements regarding preparation for delivery.

Period of Performance
The period of performance includes a base year followed by four option years.

Place of Performance
The products will be delivered to designated government facilities as specified in the solicitation.